Cargando…
The Effect of Inhaled Budesonide on the Prevention of Chronic Lung Disease in Premature Neonates with Respiratory Distress Syndrome
BACKGROUND: Considering all the latest achievements in neonatal respiratory care, bronchopulmonary dysplasia (BPD) is still among the most prevalent morbidity causes in premature infants. Involvement in this process results in longer period of hospitalization for the newborn and in the long run make...
Autores principales: | Sadeghnia, Alireza, Beheshti, Behzad Koorang, Mohammadizadeh, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843959/ https://www.ncbi.nlm.nih.gov/pubmed/29541430 http://dx.doi.org/10.4103/ijpvm.IJPVM_336_16 |
Ejemplares similares
-
Evaluation of intratracheal salbutamol effects in addition to surfactant in the clinical course of premature neonates with respiratory distress syndrome
por: Goudarzi, Razieh Moazami, et al.
Publicado: (2023) -
A comparison of surfactant administration through i-gel and ET-tube in the treatment of respiratory distress syndrome in newborns weighing more than 2000 grams
por: Sadeghnia, Alireza, et al.
Publicado: (2014) -
Early administration of surfactant via a thin intratracheal catheter in preterm infants with respiratory distress syndrome: Feasibility and outcome
por: Mohammadizadeh, Majid, et al.
Publicado: (2015) -
Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023) -
Early versus delayed initiation of nasal continuous positive airway pressure for treatment of respiratory distress syndrome in premature newborns: A randomized clinical trial
por: Badiee, Zohreh, et al.
Publicado: (2013)